Amgen To Rapidly Move Olpasiran Into Phase III For Lp(a) Reduction

 
• By Jessica Merrill
  
chess piece advancing
Amgen is advancing olpasiran into Phase III • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business